These are all fair complaints, but DB-OTO works the same way for the otoferlin-related hearing loss: it's packaged on two viral AAV vectors. It's given to much smaller babies, though there are some Chinese reports of a similar gene therapy in teens. So it's clearly not just the dual-vector but also the target etc.